Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2016-12-04 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
第七届董事会第十二次临时会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of a board meeting resolution regarding a major transaction involving issuance of shares to purchase assets and a significant asset sale. It includes detailed descriptions of the transaction structure, pricing, shareholder approvals, legal and regulatory compliance, audit and evaluation reports, and related agreements. The content focuses on the approval and procedural aspects of a major asset restructuring and related party transactions, with references to regulatory compliance and audit reports but does not itself contain full financial statements or quarterly/yearly financial results. The document is not a simple announcement or a brief summary but a comprehensive board resolution and transaction approval document. This fits best under the category of Capital/Financing Update (CAP), as it details a significant financing and capital structure change through share issuance and asset purchase/sale. It is not an Annual Report (10-K), Interim Report (IR), or Audit Report (AR) because it does not present full financial statements or audit opinions as standalone reports. It is not a Regulatory Filing (RNS) because it is a substantive transaction disclosure rather than a miscellaneous filing. Therefore, the classification is CAP with high confidence.
2016-12-04 Chinese
董事会关于评估机构的独立性、评估假设前提的合理性、评估方法与评估目的的相关性以及评估定价的公允性的意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the board of directors regarding the independence of the asset evaluation agencies, the reasonableness of evaluation assumptions, the relevance of evaluation methods to the purpose, and the fairness of the evaluation pricing. It relates to an asset purchase and sale transaction and discusses the evaluation process and results. The document is not a full annual report, audit report, or financial statement, but rather a board opinion on the evaluation related to a major asset transaction. This fits best under Board/Management Information (MANG) as it is a board statement on a significant corporate matter involving asset evaluation and transaction approval.
2016-12-04 Chinese
简式权益变动报告书（四）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report". It details the increase in shareholding by Tianjin Junruiqi Equity Investment Partnership in Chengdu Tianxing Instrument Co., Ltd. It includes detailed information about the shareholder, the nature of the shareholding change, the purpose, the method of change, and related approvals required. The document is a formal report disclosing a change in major shareholding levels, including share quantities and percentages, and references to regulatory approvals and stock exchange listings. There is no indication that this is an announcement of a report publication or a proxy solicitation, nor is it a full annual or interim financial report. The content fits the definition of a "Major Shareholding Notification" (MRQ), which is a notification of changes in significant share ownership levels crossing thresholds.
2016-12-04 Chinese
简式权益变动报告书（三）
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding proportions of the controlling shareholder (信息披露义务人) in the listed company 成都天兴仪表股份有限公司. The document includes detailed information about the shareholding changes, the reasons for the change, the transaction details, and regulatory approvals required. It references the Shenzhen Stock Exchange and the China Securities Regulatory Commission (CSRC). The content is focused on the disclosure of changes in significant share ownership and the impact on control of the company. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a proxy statement or voting results announcement. The document is a formal report on a major shareholding change, consistent with the definition of "Major Shareholding Notification (MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds. The document length and detail confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the correct classification is MRQ with high confidence.
2016-12-04 Chinese
董事会关于本次发行股份购买资产及重大资产出售暨关联交易履行法定程序的完备性、合规性及提交法律文件的有效性的说明
Regulatory Filings Classification · 95% confidence The document is a detailed explanation from the board of directors of Chengdu Tianxing Instrument Co., Ltd. regarding the legal procedures, compliance, and validity of legal documents related to a major asset restructuring involving issuance of shares to purchase assets and significant asset sales. It references multiple announcements and procedural steps taken over several months in 2016, including stock suspension, board meetings, independent director opinions, and required approvals from shareholders and regulatory authorities. The document does not contain financial statements or results but focuses on the procedural and legal compliance aspects of a major asset restructuring transaction. This fits the category of a Regulatory Filing (RNS) because it is a regulatory announcement about the progress and compliance of a major transaction, not the transaction report itself or a financial report. The document length is under 5,000 characters, and it is a formal statement by the board rather than a full report or financial disclosure.
2016-12-04 Chinese
独立董事关于发行股份购买资产及重大资产出售暨关联交易的事前认可意见
Board/Management Information Classification · 95% confidence The document is titled as an independent directors' pre-approval opinion regarding a share issuance to purchase assets and a major asset sale involving related party transactions. It references relevant laws and regulations, discusses the fairness and compliance of the transaction, and includes signatures of independent directors. The document is a formal opinion or approval statement related to a specific transaction rather than a full financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data but is a governance-related document concerning board-level approval and compliance with regulations. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or approvals by the board or senior management related to significant corporate actions.
2016-12-04 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.